Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Sep;26(3):261–265. doi: 10.1111/j.1365-2125.1988.tb05275.x

Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.

T A Burke 1, G J Sanger 1
PMCID: PMC1386537  PMID: 3179166

Abstract

1. The effects of BRL 24924 on cholinergic activity was studied in longitudinal muscle strips obtained from human stomach and colon (taenia). Contractions were evoked by exogenous acetylcholine (ACh) or by electrical field stimulation (EFS) of cholinergic neurones. Inhibitory nerve activity (predominantly non-adrenergic, non-cholinergic; NANC) was detected by measuring the relaxations evoked by EFS in the presence of atropine 1.4 microM. 2. In the stomach, BRL 24924 0.28-28 microM consistently increased the EFS-evoked contractions; lower concentrations (0.0028 and 0.028 microM) increased the contractions in most, but not all of the specimens studied. Since BRL 24924 28 microM did not affect NANC-mediated, EFS-evoked relaxations, and since high concentrations of BRL 24924 (28 and 282 microM) were required to increase ACh-evoked contractions, the increase in EFS-evoked contractions caused by BRL 24924 may be due to a facilitation of ACh release. 3. In the colon, BRL 24924 0.0028-282 microM did not affect EFS-evoked contractions. 4. BRL 24924 may therefore be regionally selective in its ability to stimulate human gastrointestinal cholinergic activity.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. L., Hawthorn J. Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret. Neuropharmacology. 1987 Sep;26(9):1367–1370. doi: 10.1016/0028-3908(87)90100-6. [DOI] [PubMed] [Google Scholar]
  2. Bennett A., Stockley H. L. The intrinsic innervation of the human alimentary tract and its relation to function. Gut. 1975 Jun;16(6):443–453. doi: 10.1136/gut.16.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchheit K. H., Costall B., Engel G., Gunning S. J., Naylor R. J., Richardson B. P. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo. J Pharm Pharmacol. 1985 Sep;37(9):664–667. doi: 10.1111/j.2042-7158.1985.tb05109.x. [DOI] [PubMed] [Google Scholar]
  4. Costall B., Gunning S. J., Naylor R. J., Tattersall F. D. Modification of electrical field stimulation-induced contractions in the guinea-pig ileum by metoclopramide and ICS 205-930 depends on the integrity of the mucosa. J Pharm Pharmacol. 1986 Nov;38(11):811–814. doi: 10.1111/j.2042-7158.1986.tb04500.x. [DOI] [PubMed] [Google Scholar]
  5. Costall B., Gunning S. J., Naylor R. J., Tyers M. B. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig. Br J Pharmacol. 1987 Jun;91(2):263–264. doi: 10.1111/j.1476-5381.1987.tb10280.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kilbinger H., Kruel R., Pfeuffer-Friederich I., Wessler I. The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):231–238. doi: 10.1007/BF00495871. [DOI] [PubMed] [Google Scholar]
  7. Miner W. D., Sanger G. J. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol. 1986 Jul;88(3):497–499. doi: 10.1111/j.1476-5381.1986.tb10228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miner W. D., Sanger G. J., Turner D. H. Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis. Br J Cancer. 1987 Aug;56(2):159–162. doi: 10.1038/bjc.1987.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sanger G. J. Activation of a myenteric 5-hydroxytryptamine-like receptor by metoclopramide. J Pharm Pharmacol. 1987 Jun;39(6):449–453. doi: 10.1111/j.2042-7158.1987.tb03418.x. [DOI] [PubMed] [Google Scholar]
  10. Sanger G. J. Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle. J Pharm Pharmacol. 1985 Sep;37(9):661–664. doi: 10.1111/j.2042-7158.1985.tb05108.x. [DOI] [PubMed] [Google Scholar]
  11. Sanger G. J. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br J Pharmacol. 1987 May;91(1):77–87. doi: 10.1111/j.1476-5381.1987.tb08985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stockley H. L., Bennett A. Relaxations mediated by adrenergic and non-adrenergic nerves in human isolated taenia coli. J Pharm Pharmacol. 1977 Sep;29(9):533–537. doi: 10.1111/j.2042-7158.1977.tb11390.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES